← 뉴스 목록
K-뷰티·의료·미용

AhealthZ Bolsters Global Presence at Taiwan Healthcare Expo 2024

Strengthening Partnerships and Showcasing Innovations in Medical Devices

AhealthZ Bolsters Global Presence at Taiwan Healthcare Expo 2024
AhealthZ and its partner companies are participating in the 2024 Taiwan Healthcare Expo, held from December 5th to 8th, to strengthen its presence in the global market.

Amid the rapid growth of Asian countries in the global medical device market, where nations like the United States have traditionally held strong positions, AhealthZ is participating in the Taiwan Healthcare Expo to accelerate efforts in strengthening its global competitiveness.

AhealthZ announced its participation in the 2024 Taiwan Healthcare Expo, which will be held from December 5th to 8th at Taipei Nangang.

The annual Taiwan Healthcare Expo serves as a platform for leading corporations with advanced medical technologies to establish strategic partnerships. It presents an excellent opportunity for domestic companies to strengthen their export competitiveness.

AhealthZ, a healthcare platform specializing in distributing diverse medical devices and pharmaceuticals, has taken significant strides this year by establishing an in-vitro diagnostics research center and building GMP-compliant manufacturing facilities, enabling it to manufacture medical devices directly. Through these advancements, the company has expanded its domestic and international efforts, particularly in East Asia, by pursuing direct investments in overseas medical institutions, engaging in joint ventures, and forming partnerships with numerous companies to enhance business collaboration.

In particular, AhealthZ aims to create synergy by attending the Taiwan Healthcare Expo alongside its investment and partnership companies. Within its promotional booth, AhealthZ will showcase the key products of these partner companies, providing a platform to highlight their innovations and strengthen collaborative opportunities.

The companies joining AhealthZ at the event include:
Mecobi (medical devices for arrhythmia treatment procedures).
TR (respiratory disease diagnostic and treatment devices).
MEDIHUB (digital 3D painless injection devices).
AIOBIO (oral disease diagnostic devices).
Through this opportunity, AhealthZ plans to enhance the global visibility of its partner companies and strengthen their collaborative relationships.

AhealthZ CEO Jun-Yeon Kim stated, “Through strategic equity investments, we have created various business opportunities and steadily expanded our presence in international markets. This event will be a prime opportunity for AhealthZ, now transformed into a comprehensive medical solutions provider, to establish strategic partnerships with even more companies.”

편집 원칙 ↗

함께 읽을 기사